Clinical Trial Update: Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction [NA]

View source ↗

Summary

Completed clinical trial evaluating the safety and effectiveness of the Tixel Fractional System for treating Meibomian gland dysfunction–related dry eye.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Meibomian Gland Dysfunction

Drugs mentioned

• Tixel Fractional System

Snippet

Sponsor: Novoxel Ltd. | Conditions: Dry Eye Syndromes, Dry Eye | NA | Status: COMPLETED | Results posted: 2024-11-15